Literature DB >> 35076798

Cost-Effectiveness of HIV Retention and Re-engagement Interventions in High-Income Countries: A Systematic Literature Review.

Margo M Wheatley1, Gregory S Knowlton1, Mary Butler1, Eva A Enns2.   

Abstract

Engagement in lifelong HIV care is critical for both patient and public health, yet there are limited resources to invest in improving HIV outcomes. We systematically reviewed evidence on the cost-effectiveness of retention and re-engagement interventions. We searched five databases for peer-reviewed studies published between 2010 and 2020. We assessed reporting and methods quality, extracted data on target populations, interventions, and cost-effectiveness, and evaluated overall strength of evidence. Eleven studies met inclusion criteria, and eight had moderate-high quality. Cost-effectiveness estimates ranged from cost-saving to over $1,000,000/quality-adjusted life year (QALY) gained. Of the 73 cost-effectiveness ratios reported, 64% were < $100,000/QALY gained. Interventions were more likely to be cost-effective when targeted to high-risk groups, implemented in locations where baseline retention levels were low, and when used in combination with other high-impact HIV interventions (such as prevention). Overall, existing evidence is moderately strong that retention and/or re-engagement interventions can be cost-effective in high-income countries.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Care continuum; Cost-effectiveness; Engagement; HIV/AIDS; Retention

Mesh:

Year:  2022        PMID: 35076798     DOI: 10.1007/s10461-021-03561-w

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  25 in total

Review 1.  Cost-effectiveness of adherence interventions for highly active antiretroviral therapy: a systematic review.

Authors:  Tim Mathes; Dawid Pieper; Sunya-Lee Antoine; Michaela Eikermann
Journal:  Int J Technol Assess Health Care       Date:  2013-06-12       Impact factor: 2.188

Review 2.  Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.

Authors:  Bruce R Schackman; Ashley A Eggman
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

Review 3.  The global north: HIV epidemiology in high-income countries.

Authors:  Patrick S Sullivan; Jeb S Jones; Stefan D Baral
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

Review 4.  Cost-effectiveness of HIV screening in high-income countries: A systematic review.

Authors:  Fabrizio Bert; Maria Rosaria Gualano; Paolo Biancone; Valerio Brescia; Elisa Camussi; Maria Martorana; Silvana Secinaro; Roberta Siliquini
Journal:  Health Policy       Date:  2018-03-23       Impact factor: 2.980

Review 5.  A systematic review on cost effectiveness of HIV prevention interventions in the United States.

Authors:  Ya-Lin A Huang; Arielle Lasry; Angela B Hutchinson; Stephanie L Sansom
Journal:  Appl Health Econ Health Policy       Date:  2015-04       Impact factor: 2.561

Review 6.  HIV screening in pregnant women: A systematic review of cost-effectiveness studies.

Authors:  Fabrizio Bert; Maria Rosaria Gualano; Paolo Biancone; Valerio Brescia; Elisa Camussi; Maria Martorana; Robin Thomas; Silvana Secinaro; Roberta Siliquini
Journal:  Int J Health Plann Manage       Date:  2017-05-29

Review 7.  What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and is it affordable?

Authors:  Valentina Cambiano; Alec Miners; Andrew Phillips
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

8.  Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC).

Authors:  Daeria O Lawson; Livia Puljak; Dawid Pieper; Stefan Schandelmaier; Gary S Collins; Romina Brignardello-Petersen; David Moher; Peter Tugwell; Vivian A Welch; Zainab Samaan; Brett D Thombs; Anders K Nørskov; Janus C Jakobsen; David B Allison; Evan Mayo-Wilson; Taryn Young; An-Wen Chan; Matthias Briel; Gordon H Guyatt; Lehana Thabane; Lawrence Mbuagbaw
Journal:  BMJ Open       Date:  2020-12-17       Impact factor: 2.692

Review 9.  HIV prevention cost-effectiveness: a systematic review.

Authors:  Omar Galárraga; M Arantxa Colchero; Richard G Wamai; Stefano M Bertozzi
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

Review 10.  The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.

Authors:  Gabriela B Gomez; Annick Borquez; Kelsey K Case; Ana Wheelock; Anna Vassall; Catherine Hankins
Journal:  PLoS Med       Date:  2013-03-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.